A trial of Insmed’s TPIP suggests daily doses of the inhaled dry powder are well tolerated and may improve blood flow in ...

A study involving more than 270,000 women found that women who work overnight were more likely to suffer from asthma.

One person was taken to the hospital for smoke inhalation treatment after a fire in Johnson City on Saturday. The Johnson ...

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change.

Insmed Incorporated (NASDAQ:INSM) is a New Jersey-based biopharmaceutical company that develops and markets therapies to ...

PVSC officials say another Sandy-like outage would spell catastrophe. Critics decry added pollution, environmental racism.

Asthma incidence in adults is positively associated with lipid accumulation product (LAP) levels, according to study findings published in Respiratory Medicine.

Some asthma therapy appeared to be less effective in Black children living in areas with high levels of nitrogen dioxide (NO2).

Guggenheim Partners called Insmed’s Phase IIb readout “impressive across the board,” with an efficacy profile that positions ...

Insmed achieved positive phase 2b results for TPIP in PAH. Click here to find out why INSM stock is a Strong Buy.

Shares of Insmed rose after the company disclosed what it called positive topline results from a study of its treatment for pulmonary arterial hypertension, or high blood pressure in the lungs. The ...

Long-acting muscarinic antagonists, as add-on therapy to inhaled corticosteroids, improve lung function parameters and reduce ...